daklinza 60mg tablets
bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 60mg
daklinza 90mg tablets
bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 90mg
daclavir 60mg film coated tablet
pharmaniaga manufacturing berhad - daclatasvir dihydrochloride -
daklinza 60 mg film-coated tablets
dksh malaysia sdn bhd - daclatasvir dihydrochloride -
daklinza 30 mg film-coated tablets
dksh malaysia sdn bhd - daclatasvir dihydrochloride -
vosevi
gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c, chronic - antivirals for systemic use - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (see sections 4.2, 4.4 and 5.1).
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitis c, chronic - antivirals for systemic use - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4.2, 4.4 and 5.1).
dacihep-30 tablets
cadila healthcare limited, india - daclatasvir dihydrochloride - tablets - 30
dacihep 60 tablets
cadila healthcare limited, india - daclatasvir dihydrochloride - tablets - 60
virdac 30 tablets 30 mg
hetero laboratories limited, india - daclatasvir dihydrochloride - tablets - 30 mg